WINTEAM PHARMA
WINTEAM PHARMA operates in Diversified Metals & Mining.
Market Cap & Net Worth: WINTEAM PHARMA (WSG)
WINTEAM PHARMA (BE:WSG) has a market capitalization of $2.22K (€2.16K) as of March 18, 2026. Listed on the BE stock exchange, this Germany-based company holds position #47135 globally and #7877 in its home market, demonstrating a -0.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WINTEAM PHARMA's stock price €0.23 by its total outstanding shares 9328 (9.33K).
WINTEAM PHARMA Market Cap History: 2015 to 2025
WINTEAM PHARMA's market capitalization history from 2015 to 2025. Data shows growth from $1.66K to $2.22K (1.97% CAGR).
WINTEAM PHARMA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WINTEAM PHARMA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
WINTEAM PHARMA's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
WINTEAM PHARMA's market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.38K | $6.53 Billion | $966.93 Million | 0.00x | 0.00x |
| 2017 | $1.72K | $8.34 Billion | $1.17 Billion | 0.00x | 0.00x |
| 2018 | $2.28K | $11.26 Billion | $1.44 Billion | 0.00x | 0.00x |
| 2019 | $2.59K | $14.32 Billion | $1.59 Billion | 0.00x | 0.00x |
| 2020 | $2.60K | $14.81 Billion | $1.66 Billion | 0.00x | 0.00x |
| 2021 | $4.34K | $19.05 Billion | $1.93 Billion | 0.00x | 0.00x |
| 2022 | $3.98K | $14.30 Billion | $764.49 Million | 0.00x | 0.00x |
| 2023 | $4.33K | $18.12 Billion | $1.29 Billion | 0.00x | 0.00x |
Competitor Companies of WSG by Market Capitalization
Companies near WINTEAM PHARMA in the global market cap rankings as of March 18, 2026.
Key companies related to WINTEAM PHARMA by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
WINTEAM PHARMA Historical Marketcap From 2015 to 2025
Between 2015 and today, WINTEAM PHARMA's market cap moved from $1.66K to $ 2.22K, with a yearly change of 1.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €2.22K | -18.88% |
| 2024 | €2.74K | -36.73% |
| 2023 | €4.33K | +8.65% |
| 2022 | €3.98K | -8.13% |
| 2021 | €4.34K | +66.53% |
| 2020 | €2.60K | +0.37% |
| 2019 | €2.59K | +13.78% |
| 2018 | €2.28K | +32.50% |
| 2017 | €1.72K | +24.88% |
| 2016 | €1.38K | -17.16% |
| 2015 | €1.66K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of WINTEAM PHARMA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.22K USD |
| MoneyControl | $2.22K USD |
| MarketWatch | $2.22K USD |
| marketcap.company | $2.22K USD |
| Reuters | $2.22K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.